Ben Arye Barak has filed 16 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 73340 shares of NovoCure Ltd ($NVCR) on March 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Stock Option (Right to Buy) | 73340 | $0.00 | 73,340.0000 | 111,981,981 | 9999.99% | 0.07% |
| March 3, 2026 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 50125 | $0.00 | 242,453.0000 | 111,981,981 | 26.06% | 0.04% |
| Feb. 28, 2026 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 17755 | $0.00 | 192,328.0000 | 111,981,981 | 10.17% | 0.02% |
| Dec. 31, 2025 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 108 | $10.99 | 174,573.0000 | 111,981,981 | 0.06% | 0.00% |
| June 30, 2025 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 769 | $15.13 | 174,465.0000 | 109,915,429 | 0.44% | 0.00% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 54975 | $18.19 | 173,696.0000 | 109,915,429 | 46.31% | 0.05% |
| Dec. 31, 2024 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 669 | $14.75 | 118,721.0000 | 0 | 0.57% | 0.00% |
| June 28, 2024 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 930 | $12.24 | 118,052.0000 | 0 | 0.79% | 0.00% |
| Dec. 31, 2023 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 128 | $12.69 | 35,323.0000 | 0 | 0.36% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 81799 | $16.30 | 117,122.0000 | 0 | 231.57% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Stock Options (Right to buy) | 125078 | $16.30 | 125,078.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 288 | $35.28 | 35,195.0000 | 0 | 0.83% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 29531 | $76.97 | 29,531.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 17755 | $0.00 | 34,907.0000 | 0 | 103.52% | 0.00% |
| Jan. 6, 2023 | NovoCure Ltd | $NVCR | Ben Arye Barak | General Counsel | A | Ordinary Shares | 150 | $62.31 | 17,152.0000 | 0 | 0.88% | 0.00% |